GPT2 Antibody (N-term)
Affinity Purified Rabbit Polyclonal Antibody (Pab)
- SPECIFICATION
- CITATIONS: 2
- PROTOCOLS
- BACKGROUND
Application ![]()
| WB, E |
---|---|
Primary Accession | Q8TD30 |
Other Accession | NP_001135938.1 |
Reactivity | Human, Mouse |
Host | Rabbit |
Clonality | Polyclonal |
Isotype | Rabbit IgG |
Calculated MW | 57904 Da |
Antigen Region | 15-44 aa |
Gene ID | 84706 |
---|---|
Other Names | Alanine aminotransferase 2, ALT2, Glutamate pyruvate transaminase 2, GPT 2, Glutamic--alanine transaminase 2, Glutamic--pyruvic transaminase 2, GPT2, AAT2, ALT2 |
Target/Specificity | This GPT2 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 15-44 amino acids from the N-terminal region of human GPT2. |
Dilution | WB~~1:1000 |
Format | Purified polyclonal antibody supplied in PBS with 0.09% (W/V) sodium azide. This antibody is purified through a protein A column, followed by peptide affinity purification. |
Storage | Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles. |
Precautions | GPT2 Antibody (N-term) is for research use only and not for use in diagnostic or therapeutic procedures. |
Name | GPT2 |
---|---|
Synonyms | AAT2, ALT2 |
Function | Catalyzes the reversible transamination between alanine and 2-oxoglutarate to form pyruvate and glutamate. |
Tissue Location | Expressed at high levels in muscle, adipose tissue, kidney and brain and at lower levels in the liver and breast |

Provided below are standard protocols that you may find useful for product applications.
Background
GPT (MIM 138200) and GPT2 (EC 2.6.1.2), also known as alanine transaminases, are pyridoxal enzymes that catalyze the reversible transamination between alanine and 2-oxoglutarate to form pyruvate and glutamate. By mediating the conversion of these 4 major intermediate metabolites, these transaminases have roles in gluconeogenesis and in amino acid metabolism.
References
Glinghammar, B., et al. Int. J. Mol. Med. 23(5):621-631(2009)
Fraser, A., et al. Hepatology 46(1):158-165(2007)
Ding, Y., et al. World J. Gastroenterol. 12(43):7038-7041(2006)
Martin, J., et al. Nature 432(7020):988-994(2004)
Yang, R.Z., et al. Genomics 79(3):445-450(2002)

If you have used an Abcepta product and would like to share how it has performed, please click on the "Submit Review" button and provide the requested information. Our staff will examine and post your review and contact you if needed.
If you have any additional inquiries please email technical services at tech@abcepta.com.
